The iShares Biotechnology ETF (IBB) experienced a significant outflow of approximately $167.3 million this week, resulting in a 2.1% decrease in shares outstanding, dropping from 48.1 million to 47.1 million. This shift reflects investor sentiment and trading activity among biotech stocks.
As for individual holdings, Vertex Pharmaceuticals (VRTX) rose by about 1%, while Regeneron Pharmaceuticals (REGN) saw a 0.6% increase. In contrast, Alnylam Pharmaceuticals (ALNY) experienced a slight decline of 0.3%. Currently, IBB’s share price is at $169.23, positioned between its 52-week low of $116.25 and high of $179.64.
The ETF’s performance is measured against its 200-day moving average, which may offer insights into its market trajectory.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
